Control strategy definition for a drug product continuous wet granulation process: Industrial case study.

Continuous manufacturing Control strategy Design space Process analytical technology Quality by Design Wet granulation

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Aug 2022
Historique:
received: 02 03 2022
revised: 22 06 2022
accepted: 27 06 2022
pubmed: 6 7 2022
medline: 17 8 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

This paper describes the specific control strategy of the commercial manufacturing process of an immediate release tablet formulation based on continuous twin-screw wet granulation. This control strategy has been defined by a multidisciplinary team using an enhanced approach, in alignment with the quality by design principles. During process development, experiments have been performed according to multivariate designs first to identify critical material attributes and critical process parameters and then, to define process conditions generating a product having the required quality. Hence, controls have been applied on critical quality attributes and on related critical process parameters and critical material attributes. Due to the specificity of the process that combines batch and continuous unit operations, a specific control strategy has been designed to ensure intermediate and end product quality. Therefore, controls including soft sensor model and in process controls have been developed to continuously monitor granules residual moisture content, assay and dissolution as granules and tablets critical attributes. In addition, process analytical technology implementation enabled increased process understanding and provided support for the development of the control strategy. This study is therefore considered as a real industrial case study of control strategy definition and implementation for an intended commercial continuous manufacturing process.

Identifiants

pubmed: 35781027
pii: S0378-5173(22)00525-7
doi: 10.1016/j.ijpharm.2022.121970
pii:
doi:

Substances chimiques

Tablets 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121970

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Pierre-François Chavez (PF)

Product Design & Performance, UCB, Braine l'Alleud, Belgium. Electronic address: pierre-francois.chavez@ucb.com.

Fanny Stauffer (F)

Product Design & Performance, UCB, Braine l'Alleud, Belgium.

Frédéric Eeckman (F)

Product Design & Performance, UCB, Braine l'Alleud, Belgium.

Nils Bostijn (N)

Product Design & Performance, UCB, Braine l'Alleud, Belgium.

David Didion (D)

Analytical Sciences for Pharmaceuticals, UCB, Braine l'Alleud, Belgium.

Cédric Schaefer (C)

Analytical Sciences for Pharmaceuticals, UCB, Braine l'Alleud, Belgium.

Hong Yang (H)

CoE Analytics, Knowledge Management & Documentation, UCB, Braine l'Alleud, Belgium.

Yousef El Aalamat (Y)

CoE Analytics, Knowledge Management & Documentation, UCB, Braine l'Alleud, Belgium.

Xavier Lories (X)

CoE Analytics, Knowledge Management & Documentation, UCB, Braine l'Alleud, Belgium.

Martin Warman (M)

Martin Warman Consultancy Ltd, Chestfield, Kent CT5 3LY, UK.

Benoit Mathieu (B)

Analytical Sciences for Pharmaceuticals, UCB, Braine l'Alleud, Belgium.

Jérôme Mantanus (J)

Product Design & Performance, UCB, Braine l'Alleud, Belgium.

Articles similaires

Animals Rumen Methane Fermentation Cannabis
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin

Fluorescent and colorimetric dual-mode recognition of Al

Liping Lin, Meng Fang, Yaojia Lin et al.
1.00
Colorimetry Hydrogen-Ion Concentration Tablets Aluminum Nitrogen
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility

Classifications MeSH